{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:40:55Z","timestamp":1792158055941,"version":"4.4.0"},"reference-count":42,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,5,15]]},"DOI":"10.2169\/internalmedicine.1931-23","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T22:53:09Z","timestamp":1696546389000},"page":"1405-1413","source":"Crossref","is-referenced-by-count":7,"title":["Lethal Arrhythmia Induced by Severe Hypokalemia with Primary Aldosteronism: A Case Report and Literature Review"],"prefix":"10.2169","volume":"63","author":[{"given":"Rei","family":"Hirose","sequence":"first","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Tsurutani","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takero","family":"Nakatsue","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akane","family":"Hirataka","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Nakai","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Saito","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 101: 1889-1916, 2016.","DOI":"10.1210\/jc.2015-4061"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gruber S, Beuschlein F. Hypokalemia and the prevalence of primary aldosteronism. Horm Metab Res 52: 347-356, 2020.","DOI":"10.1055\/a-1134-4980"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Curry P, Fitchett D, Stubbs W, Krikler D. Ventricular arrhythmias and hypokalaemia. Lancet 31: 231-233, 1976.","DOI":"10.1016\/S0140-6736(76)91029-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Geist M, Dorian P, Davies T, Greene M, Newman D. Hyperaldosteronism and sudden cardiac death. Am J Cardiol 78: 605-606, 1996.","DOI":"10.1016\/S0002-9149(96)00378-5"},{"key":"5","unstructured":"5. Abdo A, Bebb RA, Wilkins GE. Ventricular fibrillation: an extreme presentation of primary hyperaldosteronism. Can J Cardiol 15: 347-348, 1999."},{"key":"6","unstructured":"6. Delgado Y, Quesada E, P\u00e9rez Arzola M, Bredy R. Ventricular fibrillation as the first manifestation of primary hyperaldosteronism. Bol Asoc Med P R 98: 258-262, 2006."},{"key":"7","unstructured":"7. Furukawa A, Komatsu R, Itoh A, et al. Primary aldosteronism with ventricular fibrillation: a case report. J Cardiol 50: 77-82, 2007."},{"key":"8","unstructured":"8. Zelinka T, Holaj R, Petr\u00e1k O, et al. Life-threatening arrhythmia caused by primary aldosteronism. Med Sci Monit 15: CS174-CS177, 2009."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kornelius E, Chen KS, Yang YS, Huang CN. Torsade de pointes - a rare presentation of primary hyperaldosteronism. Am J Emerg Med 30: 257.e5-257.e7, 2012.","DOI":"10.1016\/j.ajem.2010.10.026"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Takamiya Y, Kitajima K, Kubota K, et al. A case of primary aldosteronism who experienced cardiopulmonary arrest, was resuscitated and cured. J Cardiol Cases 9: 63-66, 2013.","DOI":"10.1016\/j.jccase.2013.10.007"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sade E, Oto A, Oto A, et al. Adrenal adenoma presenting with torsade de pointes: a case report. Angiology 53: 471-474, 2002.","DOI":"10.1177\/000331970205300415"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Shao D, Wang S, Zhou S, et al. Aldosteronism with mild hypokalemia presenting as life-threatening ventricular arrhythmias: a case report. Medicine (Baltimore) 97: e13608, 2018.","DOI":"10.1097\/MD.0000000000013608"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ozeki Y, Tanimura Y, Nagai S, et al. Development of a new chemiluminescent enzyme immunoassay using a two-step sandwich method for measuring aldosterone concentrations. Diagnostics (Basel) 11: 433, 2021.","DOI":"10.3390\/diagnostics11030433"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Makita K, Nishimoto K, Kiriyama-Kitamoto K, et al. A novel method: super-selective adrenal venous sampling. J Vis Exp 127: 55716, 2017.","DOI":"10.3791\/55716"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Rossi GP, Auchus RJ, Brown M, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension 63: 151-160, 2014.","DOI":"10.1161\/HYPERTENSIONAHA.113.02097"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Kitamoto T, Kiriyama-Kitamoto K, Omura M, et al. Precise mapping of intra-adrenal aldosterone activities provides a novel surgical strategy for primary aldosteronism. Hypertension 76: 976-984, 2020.","DOI":"10.1161\/HYPERTENSIONAHA.119.14341"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Nakai K, Tsurutani Y, Inoue K, et al. Steroidogenic activity in unresected adrenals associated with surgical outcomes in primary aldosteronism. Hypertension 77: 1638-1646, 2021.","DOI":"10.1161\/HYPERTENSIONAHA.120.16335"},{"key":"18","unstructured":"18. Williams TA, Lenders JWM, Mulatero P, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 5: 689-699, 2017."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kardalas E, Paschou SA, Anagnostis P, Muscogiuri G, Siasos G, Vryonidou A. Hypokalemia: a clinical update. Endocr Connect 7: R135-R146, 2018.","DOI":"10.1530\/EC-18-0109"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Surawicz B. Ventricular fibrillation. J Am Coll Cardiol 5: 43B-54B, 1985.","DOI":"10.1016\/S0735-1097(85)80526-X"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 43: 155-161, 2004.","DOI":"10.1016\/j.jacc.2003.06.021"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 19: 1243-1248, 2005.","DOI":"10.1016\/j.jacc.2005.01.015"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Byrd JB, Turcu AF, Auchus RJ. Primary aldosteronism: practical approach to diagnosis and management. Circulation 21: 823-835, 2018.","DOI":"10.1161\/CIRCULATIONAHA.118.033597"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Fukuda S, Watanabe H, Daimon M, et al. Normal values of real-time 3-dimensional echocardiographic parameters in a healthy Japanese population: the JAMP-3D Study. Circ J 76: 1177-1181, 2012.","DOI":"10.1253\/circj.CJ-11-1256"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Palmer BF, Clegg DJ. Physiology and pathophysiology of potassium homeostasis: Core Curriculum 2019. Am J Kidney Dis 74: 682-695, 2019.","DOI":"10.1053\/j.ajkd.2019.03.427"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hatta K, Takahashi T, Nakamura H, Yamashiro H, Asukai N, Yonezawa Y. Hypokalemia and agitation in acute psychotic patients. Psychiatry Res 19: 85-88, 1999.","DOI":"10.1016\/S0165-1781(99)00018-9"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Okubo S, Hiejima K, Satake S, Sakamoto Y. Syncope as a manifestation of primary aldosteronism. Arch Intern Med 137: 1260, 1977.","DOI":"10.1001\/archinte.1977.03630210126038"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Struthers AD, Whitesmith R, Reid JL. Prior thiazide diuretic treatment increases adrenaline-induced hypokalaemia. Lancet 321: 1358-1361, 1983.","DOI":"10.1016\/S0140-6736(83)92140-2"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Struthers AD, Quigley C, Brown MJ. Rapid changes in plasma potassium during a game of squash. Clin Sci (Lond) 74: 397-401, 1988.","DOI":"10.1042\/cs0740397"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hendricks SK, Keroes J, Katz M. Electrocardiographic changes associated with ritodrine-induced maternal tachycardia and hypokalemia. Am J Obstet Gynecol 154: 921-923, 1986.","DOI":"10.1016\/0002-9378(86)90486-2"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Lim R, Walshaw MJ, Saltissi S, Hind CR. Cardiac arrhythmias during acute exacerbations of chronic airflow limitation: effect of fall in plasma potassium concentration induced by nebulised beta 2-agonist therapy. Postgrad Med J 65: 449-452, 1989.","DOI":"10.1136\/pgmj.65.765.449"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Abuelo JG. Low dialysate potassium concentration: an overrated risk factor for cardiac arrhythmia. Semin Dial 28: 266-275, 2015.","DOI":"10.1111\/sdi.12337"},{"key":"33","unstructured":"33. Meyer JS, Mehdirad A, Salem BI, Kulikowska A, Kulikowski P. Sudden arrhythmia death syndrome: importance of the long QT syndrome. Am Fam Physician 1: 483-488, 2003."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Chen S, Liu H, Luo P, Yu Y. Computed tomography combined with confirmatory tests for the diagnosis of aldosterone-producing adenoma. Endocr J 68: 299-306, 2021.","DOI":"10.1507\/endocrj.EJ20-0395"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Okamura T, Nakajima Y, Katano-Toki A, et al. Characteristics of Japanese aldosterone-producing adenomas with <i>KCNJ5<\/i> mutations. Endocr J 64: 39-47, 2017.","DOI":"10.1507\/endocrj.EJ16-0243"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Inoue K, Yamazaki Y, Kitamoto T, et al. Aldosterone suppression by dexamethasone in patients with <i>KCNJ5<\/i>-mutated aldosterone-producing adenoma. J Clin Endocrinol Metab 103: 3477-3485, 2018.","DOI":"10.1210\/jc.2018-00738"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Yamazaki Y, Omata K, Tezuka Y, et al. Tumor cell subtypes based on the intracellular hormonal activity in <i>KCNJ5<\/i>-mutated aldosterone-producing adenoma. Hypertension 72: 632-640, 2018.","DOI":"10.1161\/HYPERTENSIONAHA.118.10907"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Goto A, Takahashi Y, Kishimoto M, et al. Primary aldosteronism associated with severe rhabdomyolysis due to profound hypokalemia. Intern Med 48: 219-223, 2009.","DOI":"10.2169\/internalmedicine.48.1444"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Cooray MS, Bulugahapitiya U, Peiris D. Rhabdomyolysis: a rare presentation of aldosterone-producing adenoma. Indian J Endocrinol Metab 17: S237-S239, 2013.","DOI":"10.4103\/2230-8210.119583"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Alam S, Kandasamy D, Goyal A, et al. High prevalence and a long delay in the diagnosis of primary aldosteronism among patients with young-onset hypertension. Clin Endocrinol (Oxf) 94: 895-903, 2021.","DOI":"10.1111\/cen.14409"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Lim YY, Shen J, Fuller PJ, Yang J. Current pattern of primary aldosteronism diagnosis: delayed and complicated. Aust J Gen Pract 47: 712-718, 2018.","DOI":"10.31128\/AJGP-05-18-4587"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Wachtel H, Fraker DL. Therapeutic outcomes with surgical and medical management of primary aldosteronism. Curr Cardiol Rep 23: 89, 2021.","DOI":"10.1007\/s11886-021-01516-0"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/10\/63_1931-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T03:27:27Z","timestamp":1716002847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/10\/63_1931-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1931-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,15]]},"article-number":"1931-23"}}